Tier 2 · Educated
Compliance Alerts

Compliance Alerts.
Same-day. Operator-actionable. Cited.

When DCC, CDTFA, the legislature, or the federal government moves, you know the same day — with the operator action translated, not just the press release linked.

Subscribe to alerts or call (800) 555-0199
The promise

Same day.

When DCC, CDTFA, or the legislature moves, you know inside 24 hours — with the operator action translated, not just the press release linked.

The feed

What lands in your inbox.

Real alerts from this month. Severity color-coded. Always cited. Always translated for operators.

GreenState Compliance Alerts · April 2026
Federal · DOJApr 22 · 4:11 PM

DOJ moves state-licensed medical cannabis to Schedule III

Final rule published in the Federal Register today reschedules state-licensed medicinal cannabis. 280E treatment shifts for medical lines; adult-use treatment unchanged. June 29 DEA hearing pending on broader scope.

Affects: Retail, Distribution, ManufacturingRead briefing →
CDTFAApr 19 · 9:02 AM

AB 564 excise rate confirmed at 15% through June 2028

CDTFA bulletin reaffirms the 15% gross-receipts excise rate locked through June 30, 2028. POS configuration check recommended; receipt-disclosure language unchanged.

Affects: Retail (Type 9, Type 10)Read briefing →
DCCApr 17 · 2:44 PM

SB 540 retailer brochure rule — enforcement window opens

DCC field staff begin verifying SB 540 brochure compliance at storefront and online points of sale. Both languages required. Citation matrix posted to inspector handbooks.

Affects: Retail Type 9, Type 10, Type 12Read briefing →
DCCApr 14 · 11:30 AM

AB 1894 vape labeling — integrated-vaporizer disclosure language

DCC issues clarifying guidance on AB 1894 informational-panel requirements for integrated vaporizers. Brand owners notified; new label artwork required at next print run.

Affects: Manufacturing Type 6, Type 7, PRead briefing →
Federal · DEAApr 11 · 5:55 PM

DEA hearing scheduled June 29 on adult-use rescheduling scope

Public hearing notice published. Comment window opens May 6. Operational impact for California licensees still indirect; we will brief if scope shifts.

Affects: All license types (informational)Read briefing →
DCCApr 8 · 10:15 AM

LPA-10 threshold change — financial-interest disclosure trigger

Limited Partner Aggregation threshold drops to 10% effective May 15. Re-disclosure of financial-interest holders required from any licensee with ownership stack changes since 2024 renewal.

Affects: All license typesRead briefing →
Local · Los AngelesApr 4 · 3:20 PM

LA City DCR posts revised social-equity verification timeline

Department of Cannabis Regulation publishes new processing windows for Tier 1 and Tier 2 equity applicants. Pending applications routed to a refreshed queue.

Affects: LA City Retail, Delivery applicantsRead briefing →
AB/SBApr 2 · 8:48 AM

SB 1186 medical-delivery preemption clarified by Appropriations

Senate Appropriations adds clarifying language to the SB 1186 framework on local medical-delivery preemption. No operator action required at this time.

Affects: Type 9 delivery, statewideRead briefing →
Why this matters

The 2025–2026 rule cycle
does not slow down.

Federal rescheduling. AB 564 excise framework. SB 540 retailer brochure. AB 1894 vape labeling. SB 1186 medical-delivery preemption. The LPA threshold drop. Any one missed sweep is the citation in the next inspection notice.

Apr 22
Federal Schedule III
DOJ rescheduled state-licensed medicinal cannabis on April 22, 2026. The 280E posture for medical lines changed in a single calendar day — with the broader DEA hearing still pending.
15%
AB 564 excise, locked to 2028
The retail excise rate is now fixed by statute through June 30, 2028. POS configurations, receipt-disclosure language, and price-ladder math all have to line up with the legislative number, not the prior CDTFA-set rate.
Mar 1
SB 540 brochure live
Storefront and online points of sale must present the SB 540 retailer brochure in both required languages. The miss is a citation, not a warning — and the rule has been enforceable since March 1, 2025.
What you get

Filtered. Cited. Actionable.

01

Same-day alerts

Critical changes hit your inbox the day they publish, not the next monthly digest.

02

Authority-source filter

Pick your sources: DCC, CDTFA, state legislature, federal/DEA, your local jurisdiction.

03

License-type filtered

Alerts scoped to your license types and SKUs — no noise from rules that do not touch you.

04

Operator-actionable

Each alert names what to change, who owns it, and the citation behind it. Not just news.

Your inbox this week

Quiet weeks stay quiet.

A compact view of the last seven days. No alert is published unless it changes something operators do.

Apr 22
DOJ Schedule III rule publishedFederal · DOJ · affects retail, distribution, manufacturing
Apr 19
CDTFA reaffirms 15% excise through June 2028CDTFA · affects all retailers
Apr 17
SB 540 brochure enforcement window opensDCC · affects Type 9, 10, 12
Apr 14
AB 1894 vape labeling guidance issuedDCC · affects Type 6, 7, P
A single alert, in full

What lands at 8am Monday.
Not a press release. An operator’s next move.

Most regulatory news services link the agency’s announcement and call it a day. Compliance Alerts translates the announcement into the operator’s next action — with the named CCR/BPC anchor, the affected license types, and the deadline that started the moment the rule landed.

Critical Federal · April 22, 2026 21 USC §812

DOJ Schedule III rescheduling now in effect for state-licensed medicinal cannabis

The DOJ’s administrative action under 21 USC §812 reschedules state-licensed medicinal cannabis to Schedule III. IRC §280E only applies to Schedule I/II controlled substances — medical operators no longer fall inside its scope. Adult-use remains Schedule I; the broader DEA rescheduling hearing is set for June 29, 2026.

Affects
Type 9, Type 10, Type 12 licensees with medical SKUs · Distribution Type 11 carrying medical product · Manufacturing Types 6, 7, N for medical formulations
Operator actions, this week
  1. Open the conversation with your CPA on amended-return posture for medical-channel revenue.
  2. Segregate medical vs adult-use revenue lines for tax-year 2026 filing.
  3. Track the June 29, 2026 DEA hearing for broader rescheduling implications.
  4. Coordinate with retained tax counsel before acting on any §280E decision.
Read the full operator briefing →
Alerts vs the alternatives

Three things that look similar.
Only one tells you what to do.

News

Tells you something happened.

A reporter’s framing. A trade publication’s analysis. Useful for context. Not citation-anchored. Not actionable on its own.

Press release

Tells you the agency’s framing.

DCC’s announcement. CDTFA’s notice. Authoritative on what the agency wants you to know. Silent on what it means for your specific license type.

Compliance Alert

Tells you what to do, by when, with the citation.

Named CCR/BPC anchor. Affected license types. Deadline. Operator action list. Routes into your Compliance Control Center as a scheduled task.

“When the rule changes, the meeting is already on your calendar.”
The integration thesis · Why alerts route into the Control Center
Subscribe

Same-day alerts.
From $295 / month.

Subscribe to alerts See pricing